Audit 28472

FY End
2022-12-31
Total Expended
$97.34M
Findings
0
Programs
23
Organization: Path (WA)
Year: 2022 Accepted: 2023-06-12
Auditor: Clark Nuber P S

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
98.U08 Infectious Disease Detection and Surveillance (idds) $3.77M - 0
98.RD Usaid Malaria Vaccine $3.36M - 0
98.U01 Eradicate Tb Activity $2.51M - 0
98.U10 Prevention of Mosquito-Borne Diseases Through Vector Control Idiq/task Order #1 $840,817 - 0
98.U11 Expanding Tuberculosis Identification, Treatment, and Prevention in Central Asia $362,998 - 0
98.U09 The Demographics and Health Surveys Program (dhs-8) $350,379 - 0
98.U05 Testing and Technical Assistance for Rapid Test Kits $322,242 - 0
11.619 Arrangements for Interdisciplinary Research Infrastructure $312,584 - 0
98.U07 Senegal: Scale Up of Malaria Case Investigations III (fara) $288,161 - 0
93.318 Protecting and Improving Health Globally: Building and Strengthening Public Health Impact, Systems, Capacity and Security $103,531 - 0
93.989 International Research and Research Training $90,830 - 0
93.855 Allergy, Immunology and Transplantation Research $66,280 - 0
98.U04 Usaid Global Health Quality Assurance (ghqc) Program $53,577 - 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $46,037 - 0
93.865 Child Health and Human Development Extramural Research $41,612 - 0
93.RD Collaborative Influenza Vaccine Innovation Center (civic) $30,511 - 0
98.U06 Assessment of An All-Oral, Shorter Treatment Regimen for Extensively Drug-Resistant Tuberculosis (xdr-Tb) and Fluoroquin $11,365 - 0
93.350 National Center for Advancing Translational Sciences $9,216 - 0
98.685 Senegal: Scale Up of Malaria Case Investigations $-330 - 0
98.U02 Hiv Service Delivery Support Activity (hsdsa) $-1,122 - 0
98.001 Usaid Foreign Assistance for Programs Overseas $-4,684 Yes 0
98.U03 Demographic and Health Surveys Program: Phase IV $-15,739 - 0
93.067 Global Aids $-55,908 - 0

Contacts

Name Title Type
PD3VNAABZJL7 Kelly Priestley Auditee
2062853500 Andrew Prather Auditor
No contacts on file

Notes to SEFA

Accounting Policies: Note 1 Basis of PresentationThe accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activityof PATH under programs of the federal government for the year ended December 31, 2022. The information inthis Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part200, Uniform Administrative Requirements, Cost Principles and Audit Requirements for Federal Awards (UniformGuidance). Because the Schedule presents only a selected portion of the operations of PATH, it is not intendedto and does not present the financial position, changes in net assets or cash flows of PATH.Note 2 Summary of Significant Accounting PoliciesExpenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures arerecognized following, as applicable, either the cost principles contained in the Uniform Guidance, whereincertain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown onthe Schedule represent adjustments or credits made in the normal course of business to amounts reported asexpenditures in prior years.Passthrough entity identifying numbers are presented where available.PATH has not elected to use the 10percent de minimis indirect cost rate as allowed under the UniformGuidance. De Minimis Rate Used: N Rate Explanation: The auditee did not use the de minimis cost rate.